Bisphenol A Exposure and Its Link to Obesity and Metabolic Syndrome Bisphenol A, commonly known as BPA, raises serious health concerns. This chemical appears in many everyday plastic products. Researchers now link BPA exposure to higher risks of obesity and metabolic syndrome. How BPA Affects the Body BPA acts as an endocrine disruptor. It interferes […]
Role of Type I Interferon Signature as a Biomarker for Treatment Response to New Biologics in SLE Systemic lupus erythematosus (SLE) is a complex autoimmune disease. It affects multiple organs and shows highly variable patient responses to treatment. Doctors now focus on the type I interferon signature as a promising biomarker. This signature helps predict […]
Pediatric Rheumatology in Europe: Analysis of Juvenile Idiopathic Arthritis Outcomes from EUROPAIN and Other Registries Pediatric rheumatology has grown significantly across Europe. Specialists focus on early diagnosis and effective management of childhood rheumatic diseases. Juvenile Idiopathic Arthritis (JIA) stands as the most common chronic rheumatic condition in children. Researchers actively study outcomes through large registries […]
Janus Kinase Inhibitors in Refractory Dermatomyositis and Systemic Sclerosis: Clinical Outcomes and Molecular Mechanism Analysis Janus Kinase (JAK) inhibitors have emerged as promising treatments for difficult-to-treat rheumatic diseases. Doctors use these drugs for patients with refractory dermatomyositis and systemic sclerosis. These conditions often resist conventional therapies. Researchers now study both clinical results and underlying molecular […]
Comparative Effectiveness and Safety of JAK Inhibitors Versus Biologics in Refractory Rheumatoid Arthritis Doctors often face challenges while treating refractory rheumatoid arthritis (RA). Patients show poor response to standard therapies. Researchers now compare JAK inhibitors with biologics to find better options. JAK inhibitors include tofacitinib, baricitinib, upadacitinib, and ivarmacitinib. These oral drugs block specific enzymes […]
Comparative Effectiveness of Different RA Treatment Protocols Using Large US Registry Data Rheumatoid arthritis (RA) affects millions of Americans. Doctors use various treatment protocols to manage this chronic condition. Researchers now compare these treatments through large US registry data. This approach delivers real-world evidence. Moreover, it helps improve patient outcomes across the country. Scientists analyze […]